Survival outcomes of neoadjuvant chemotherapy-related strategies compared with concurrent chemoradiotherapy for locally advanced cervical cancer: a meta-analysis of randomized controlled trials
ConclusionBased on traditional meta-analysis, CRT was better than NAC + RT in terms of OS. Carboplatin instead of cisplatin as part of the NAC + RT strategy or gemcitabine use in NAC + CRT may not be a good choice. An increased total dosage of paclitaxel and/or cisplatin as part of NAC + CRT and CRT strategies may improve the survival outcome of LACC patients.
Source: Archives of Gynecology and Obstetrics - Category: OBGYN Source Type: research
More News: Cancer | Cancer & Oncology | Cervical Cancer | Chemotherapy | Hysterectomy | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | OBGYN